Discover published sets by community

Primary pediatric indication: ADHD; Dosing concerns: Adjust doses based on weight and response.

Primary pediatric indication: ADHD; Dosing concerns: Hepatic impairment requires dosage adjustment.

Primary pediatric indication: Major Depressive Disorder & OCD; Dosing concerns: Start with lower doses due to risk of increased suicidal ideation.

Primary pediatric indication: OCD; Dosing concerns: Monitor for weight loss and growth inhibition in pediatric patients.

Primary pediatric indication: Autistic disorder irritability; Dosing concerns: Risk of weight gain and metabolic syndrome, start low, go slow.

Primary pediatric indication: Autistic disorder irritability, bipolar I, schizophrenia; Dosing concerns: Weight, metabolic monitoring, and dose adjustments for CYP2D6 inhibitors.

Primary pediatric indication: ADHD; Dosing concerns: Dose needs to be tapered to discontinue to avoid rebound hypertension.

Primary pediatric indication: ADHD; Dosing concerns: Caution with dosing due to potential for hypotension and bradycardia.

Primary pediatric indication: ADHD; Dosing concerns: Prodrug, dose based on weight and conversion to active form.

Primary pediatric indication: ADHD; Dosing concerns: Consider cardiovascular risks and potential for abuse.

Primary pediatric indication: Bipolar disorder, seizures; Dosing concerns: Hepatic function monitoring and potential teratogenic effects.

Primary pediatric indication: Bipolar disorder, seizures; Dosing concerns: Need to titrate slowly to minimize the risk of rash.

Primary pediatric indication: Bipolar disorder; Dosing concerns: Narrow therapeutic index, requires blood level monitoring.

Primary pediatric indication: Major Depressive Disorder & generalized anxiety disorder; Dosing concerns: Consider dose adjustment in hepatic and renal impairment.

Primary pediatric indication: ADHD; Dosing concerns: Extended-release formulation allows for once-daily dosing, monitor for insomnia.

Primary pediatric indication: ADHD; Dosing concerns: Extended-release formulation provides all-day symptom control, monitor for weight loss.

Primary pediatric indication: ADHD; Dosing concerns: Extended-release amphetamine blend, monitor for drug dependence.

Primary pediatric indication: Bipolar disorder, schizophrenia; Dosing concerns: Monitor for metabolic syndrome and adjust dose in hepatic impairment.

Primary pediatric indication: Bipolar disorder, schizophrenia; Dosing concerns: Take with food to improve absorption, monitor ECG for QT prolongation.